The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors— lessons from normal and immunodeficient mice IM SvaneM BoesenA-M Engel Review 01 December 1999 Pages: 223 - 238
Distribution of 2-chloro-2′-deoxyadenosine, 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine, Fludarabine and Cytarabine in mice: a whole-body autoradiography study Synnöve LindemalmJan LiliemarkFreidoun Albertioni Original Paper 01 December 1999 Pages: 239 - 244
Reduced bone marrow stem cell pool and progenitor mobilisation in multiple myeloma after melphalan treatment L Meldgaard KnudsenT RasmussenHE Johnsen Original Paper 01 December 1999 Pages: 245 - 254
Long-term results after combined modality treatment for non-metastatic osteosarcoma J AparicioA SeguraB Munárriz Original Paper 01 December 1999 Pages: 255 - 260
Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282 Y NovikLM RyanA Schutt Original Paper 01 December 1999 Pages: 261 - 266
Synergistic antitumour effects of chemo-immunotherapy with an oxazaphosphorine drug and IL-2-secreting cells in a mouse colon cancer model H KusnierczykE Pajtasz-PiaseckaC Radzikowski Original Paper 01 December 1999 Pages: 267 - 278
Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination Edward A StadtmauerDonald E TsaiLeslie E Silberstein Original Paper 01 December 1999 Pages: 279 - 288
Cytokine expression in B-CLL in relation to disease progression andin vitro activation M Aguilar-SantelisesD GigliottiM Jondal Original Paper 01 December 1999 Pages: 289 - 295